You Position: Home > Paper
Prophylactic effects of nasal tolerance with dual analogue on experimental autoimmune myasthenia gravis in Lewis rats
( views:294, downloads:4 )
- Author:
- No author available
- Journal Title:
- CHINESE JOURNAL OF NEUROMEDICINE
- Issue:
- 1
- DOI:
- 10.3760/cma.j.issn.1671-8925.2004.01.004
- Key Word:
- 实验性自身免疫性重症肌无力(EAMG);双类似物;鼻粘膜耐受;预防作用
Abstract： 目的选择双类似物(Lys262-Ala207)通过不同时间点对实验性自身免疫性重症肌无力(EAMG)模型进行鼻粘膜耐受预防性给药,观察其临床及免疫指标变化,并评价疗效,探讨预防性鼻粘膜耐受在EAMG中的预防作用机制.方法应用乙酰胆碱受体(AChR)加CFA致敏Lewis大鼠建立EAMG模型,并在致敏前10 d(预防耐受A组)及致敏当日(预防耐受B组)给予耐受肽Lys262-Ala207及相应对照组CA、CB采用相同剂量对照肽MBP-p83-99鼻腔给药.检测给药后A、B组及相应对照组大鼠的体重、临床评分、肌电图、肌肉中AChR含量丢失变化及致敏第42 d血清抗AChR抗体IgG含量.结果急性期和慢性期A、B组体重明显超过相应对照组,临床症状明显轻于相应对照组,慢性期A组体重明显超过B组、病情明显轻于B组;A、B组低频重复电刺激出现衰减反应D5阳性率低于相应对照组;A、B组肌肉AChR含量丢失分别明显低于相应对照组,而A组低于B组;慢性期42 d A、B组lgG含量明显低于相应对照组,同时A组明显低于B组.结论本实验表明,预防耐受的疗效与自身免疫启动时间有关,启动前优于启动时耐受;双类似物鼻粘膜耐受预防不仅可有效地抑制临床症状,且可特异性减低致病性循环抗体含量和减少神经肌接头AChR含量丢失,为采用双类似物鼻粘膜耐受防治人类重症肌无力(MG)提供了依据.
- [1]富羽弘,王化冰,王丽华,等.设计耐受原并用鼻黏膜耐受治疗EAMG的方法学研究[J].2002,(4).
- [2]Paas Rozner-M,Paas Y,Dayan M,etc.Oral administration of a dual analog of two myasthenogenic T cell epitopes down-regulates experimental autoimmune myasthenia gravis in mice.[J].2000,97(5).
- [3]F D, Shi,X F, Bai,H L, Li,etc.Nasal tolerance in experimental autoimmune myasthenia gravis (EAMG): induction of protective tolerance in primed animals.[J].1998,111(3).
- [4]王维治,王丽宏,杨秋霞.实验性自身免疫性脑脊髓炎豚鼠鼻粘膜免疫耐受研究[J].1999,(6).
- [5]马存根.Suppression of Experimental Autoimmune Myasthenia Gravis by Nasal Administration of Acetylcholine Receptor[J].1995,(1).
- [6]Im SH,Katchalski Katzir-E,Venkatesh N,etc.Prevention of passively transferred experimental autoimmune myasthenia gravis by a phage library-derived cyclic peptide.[J].2000,97(2).
- [7]V A, Lennon,E H, Lambert,K R, Leiby,etc.Recombinant human acetylcholine receptor alpha-subunit induces chronic experimental autoimmune myasthenia gravis.[J].1991,146.
- [8]Ma, C.-G.,Zhang, G.-X.,Xiao, B.-G.,etc.Cellular mRNA expression of interferon-gamma (IFN-γ), IL-4 and transforming growth factor-beta (TGF-β) in rats nasally tolerized against experimental autoimmune myasthenia gravis (EAMG).[J].1996,104(3).
- [9]王增钰,乔健.乙酰胆碱受体制剂对实验性自身免疫性重症肌无力的抑制作用[J].1994,(3).
- [10]J, Lindstrom,D, Shelton,Y, Fujii.Myasthenia gravis.[J].1988,42.